Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study.

Eberhardson, M; Söderling, J K; Neovius, M; Cars, T; Myrelid, P; Ludvigsson, J F; Askling, J; Ekbom, A; Olén, O

Eberhardson, M; Söderling, J K; Neovius, M; Cars, T; Myrelid, P; Ludvigsson, J F; Askling, J; Ekbom, A; Olén, O.

Affiliation

Eberhardson M; Danderyd's Hospital, Stockholm, Sweden.
Söderling JK; Karolinska Institutet, Stockholm, Sweden.
Neovius M; Karolinska Institutet, Stockholm, Sweden.
Cars T; Karolinska Institutet, Stockholm, Sweden.
Myrelid P; Public Healthcare Service, Stockholm, Sweden.
Ludvigsson JF; Uppsala University, Uppsala, Sweden.
Askling J; Linköping University, Linköping, Sweden.
Ekbom A; County Council of Östergötland, Linköping, Sweden.
Olén O; Karolinska Institutet, Stockholm, Sweden.

Aliment Pharmacol Ther ; 46(6): 589-598, 2017 09.

Article in En | MEDLINE | ID: mdl-28752637

Subject(s)

Crohn Disease/drug therapy; Digestive System Surgical Procedures/statistics & numerical data; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Adalimumab/therapeutic use; Adolescent; Adult; Child; Child, Preschool; Cohort Studies; Female; Humans; Incidence; Infant; Infliximab/therapeutic use; Male; Middle Aged; Registries; Risk; Sweden/epidemiology; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Digestive System Surgical Procedures / Crohn Disease / Tumor Necrosis Factor-alpha Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Aliment Pharmacol Ther Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google